Primum non nocere. The SARS-CoV-2 pandemic course in oldest
Main Article Content
Keywords
COVID 19
Abstract
Dramatic outcomes of Covid-19 pandemia in Italy, in particular in the North, must be discussed. Maybe a bad strategy and lack of timely intervention togheter with concurrent social events, comorbidities of oldest persons, bed rest, inadequate nutritional support and drugs’ side effects and infection of health professionals proved fatal for many.
Downloads
References
2-FDA, April 2020: Letter to healthcare providers: Important Information on the Use of Serological (Antibody) Tests for COVID-19
3- Shufa Zheng,, Jian Fan, Fei Yu, et al Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
BMJ 2020;369:m1443
4- Han HY, Yi Liu YI, ,; Zhou Liyuan, PhD1; et al Epidemiological Assessment of Imported Coronavirus Disease 2019 (COVID-19) Cases in the Most Affected City Outside of Hubei Province, Wenzhou, China Research letter April 23, 2020,JAMA Netw Open. 2020;3(4):e206785. doi:10.1001/jamanetworkopen.2020.6785
5. NIH - Tuesday, April 21, 2020 Expert U.S. panel develops NIH treatment guidelines for COVID-19
6- Spinato G., Fabbris C., Polesel P.,et al Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection , JAMA. Published online April 22, 2020. doi:10.1001/jama.2020.6771
7- Ferretti L., Wymant C.,Kendall M et al. Quantifying SARS-COV-2 transmission suggests epidemic control with digital contact tracing Science 31 Mar 2020:eabb6936
Article Sidebar
Article Details
How to Cite
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.